Restricted accessResearch articleFirst published online 2025-03
Chrysanthemum Zawadskii Var. and Platycodon Grandifloras Extract Mixture Protects Against Lipopolysaccharide-Induced Pulmonary Inflammation and Cyclophosphamide-Induced Immune Deficiency: In Vivo Evidence
Respiratory tract diseases (RTDs) cause airflow limitations and impaired respiratory function, primarily due to pulmonary inflammation and immune dysfunction. Chrysanthemum zawadskii var. latilobum Kitamur and Platycodon grandifloras (CP) are traditional herbs known for their anti-inflammatory and immune-enhancing properties. This study investigates the anti-inflammatory and immune-enhancing effects of a combined extract of CP in vivo. CP was prepared by mixing equal volumes of Chrysanthemum zawadskii extract (CE) and Platycodon grandifloras extract (PE) at the same concentration. The anti-inflammatory effects of CP were evaluated using a lipopolysaccharide (LPS)-induced inflammation model in BALB/c mice. The immune-enhancing effects were assessed using a cyclophosphamide (CYP)-induced immunosuppression model. Protein and mRNA expressions of inflammatory and immune markers were analyzed through Western blotting and quantitative real-time PCR. CP significantly reduced LPS-induced pulmonary inflammation by decreasing interleukin (IL)-1β and cyclooxygenase-2 expression in lung tissues. In the CYP-induced model, CP treatment restored spleen and thymus weights, reversed reductions in immune cell counts, and increased TNF-α and IL-2 mRNA expression in the spleen. In conclusion, CP inhibits pulmonary inflammation by suppressing inflammatory mediators and enhances immune function by increasing immune-related indicators. This suggests that CP may have potential therapeutic applications for treating respiratory inflammation and related diseases.
Get full access to this article
View all access options for this article.
References
1.
WheeldonA. The respiratory system and associated disorders. Br J Nurs, 2023; 32(13):613–619; doi: 10.1296/8/bjon.2023.32.13.613
2.
HongYJ, ChoiJH, HongMH, et al.Neuregulin-1 suppresses anti-apoptotic effect of Der p 38 on neutrophils by inhibition of cytokine secretion. Mol Cell Toxicol, 2023; 19(4):857–867; doi: 10.1007/s13273-023-00375-w
3.
ReedKD.Chapter 84 - Respiratory Tract Infections: A Clinical Approach. In: Molecular Medical Microbiology (TangY-W, SussmanM, LiuD, et al. eds.) Academic Press: Boston; 2015; pp. 1499–1506.
4.
KakhakiHES, AlesaeidiS, SiriG, et al.Diaphragmatic ultrasound advantages in chronic obstructive pulmonary disease (COPD) patients: A systematic review and metaanalysis. Ethiop J Health Sci, 2023; 33(5):903–912; doi: 10.4314/ejhs.v33i5.20
5.
ChoSB, KimIK, KangHS, et al.S100A8/A9-RAGE pathway and chronic airway inflammation in smoke-induced lung carcinogenesis. Mol Cell Toxicol, 2024; 20(1):177–186; doi: 10.1007/s13273-023-00339-0
6.
CaiY, SchikowskiT, AdamM, et al.Cross-sectional associations between air pollution and chronic bronchitis: An ESCAPE meta-analysis across five cohorts. Thorax, 2014; 69(11):1005–1014; doi: 10.1136/thoraxjnl-2013-204352
7.
KazemiparkouhiF, EumKD, WangB, et al.Long-term ozone exposures and cause-specific mortality in a US Medicare cohort. J Expo Sci Environ Epidemiol, 2020; 30(4):650–658; doi: 10.1038/s41370-019-0135-4
8.
LiuS, ZhouY, LiuS, et al.Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: Results from a cross-sectional study in China. Thorax, 2017; 72(9):788–795; doi: 10.1136/thoraxjnl-2016-208910
9.
SchikowskiT, SugiriD, RanftU, et al.Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res, 2005; 6(1):152; doi: 10.1186/1465-9921-6-152
10.
ZanobettiA, BindMA, SchwartzJ. Particulate air pollution and survival in a COPD cohort. Environ Health, 2008; 7:48; doi: 10.1186/1476-069x-7-48
11.
ZhaoJ, LiM, WangZ, et al.Role of PM2.5 in the development and progression of COPD and its mechanisms. Respir Res, 2019; 20(1):120; doi: 10.1186/s12931-019-1081-3
12.
LeeJM, Weerasinghe-MudiyanselagePDE, KimB, et al.Impact of diesel particulate matter on the olfactory bulb of mice: Insights from behavioral, histological, and molecular assessments. Mol Cell Toxicol, 2024; 20(3):735–745; doi: 10.1007/s13273-023-00414-6
13.
LeeSY, ChoJH, ChoSS, et al.Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation. Lab Anim Res, 2018; 34(1):1–10; doi: 10.5625/lar.2018.34.1.1
14.
HåkanssonHF, SmailagicA, BrunmarkC, et al.Altered lung function relates to inflammation in an acute LPS mouse model. Pulm Pharmacol Ther, 2012; 25(5):399–406; doi: 10.1016/j.pupt.2012.08.001
15.
TschernigT, JanardhanKS, PabstR, et al.Lipopolysaccharide induced inflammation in the perivascular space in lungs. J Occup Med Toxicol, 2008; 3:17; doi: 10.1186/1745-6673-3-17
16.
PuljicR, BenediktusE, Plater-ZyberkC, et al.Lipopolysaccharide-induced lung inflammation is inhibited by neutralization of GM-CSF. Eur J Pharmacol, 2007; 557(2–3):230–235; doi: 10.1016/j.ejphar.2006.11.023
17.
ZouY, ChenX, XiaoJ, et al.Neutrophil extracellular traps promote lipopolysaccharide-induced airway inflammation and mucus hypersecretion in mice. Oncotarget, 2018; 9(17):13276–13286; doi: 10.1863/2/oncotarget.24022
18.
ShenH-T, FangY-T, TsaiW-H, et al.A Lactobacillus combination ameliorates lung inflammation in an Elastase/LPS—induced mouse model of chronic obstructive pulmonary disease. Probiotics Antimicrob Proteins, 2024; doi: 10.1007/s12602-024-10300-9
19.
PatrawalaM, CuiY, PengL, et al.Pulmonary disease burden in primary immune deficiency disorders: Data from USIDNET Registry. J Clin Immunol, 2020; 40(2):340–349; doi: 10.1007/s10875-019-00738-w
20.
HeR, LuZ, ZhangL, et al.The clinical course and its correlated immune status in COVID-19 pneumonia. J Clin Virol, 2020; 127:104361; doi: 10.1016/j.jcv.2020.104361
21.
AkbariH, TabriziR, LankaraniKB, et al.The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Life Sci, 2020; 258:118167; doi: 10.1016/j.lfs.2020.118167
22.
ChangY, BaiM, YouQ. Associations between Serum Interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis. Biomed Res Int, 2022; 2022:2755246; doi: 10.1155/2022/2755246
23.
ByunJ-H, ChoiC-W, JangM-J, et al.Anti-Osteoarthritic Mechanisms of Chrysanthemum zawadskii var. latilobum in MIA-Induced Osteoarthritic Rats and Interleukin-1β-Induced SW1353 Human Chondrocytes. Medicina (Kaunas), 2020; 56(12):685; doi: 10.3390/medicina56120685
24.
LeeT, NaCB, KimD, et al.Osteoarthritis improvement effect of Chrysanthemum zawadskii var. latilobum extract in relation to genotype. Int J Vitam Nutr Res, 2023; 93(5):410–419; doi: 10.1024/0300-9831/a000745
25.
LiZ, LiJ, GuL, et al.Chrysanthemum zawadskii extract induces hair growth by stimulating the proliferation and differentiation of hair matrix. Int J Mol Med, 2014; 34(1):130–136; doi: 10.3892/ijmm.2014.1768
26.
YooA, JangYJ, AhnJ, et al.Chrysanthemi zawadskii var. latilobum attenuates obesity-induced skeletal muscle atrophy via regulation of PRMTs in skeletal muscle of mice. Int J Mol Sci, 2020 Apr 17;21(8):2811; doi: 10.3390/ijms21082811
27.
KimHL, ParkJ, JungY, et al.Platycodin D, a novel activator of AMP-activated protein kinase, attenuates obesity in db/db mice via regulation of adipogenesis and thermogenesis. Phytomedicine, 2019; 52:254–263; doi: 10.1016/j.phymed.2018.09.227
28.
LianW, GeS, PangQ. Platycodin D ameliorates ammonia-induced pulmonary fibrosis by repressing TGF-β1-mediated extracellular matrix remodeling. Chem Biol Drug Des, 2024; 103(1):e14446; doi: 10.1111/cbdd.14446
29.
LiuY, ChenQ, RenR, et al.Platycodon grandiflorus polysaccharides deeply participate in the anti-chronic bronchitis effects of Platycodon grandiflorus decoction, a representative of “the lung and intestine are related. Front Pharmacol, 2022; 13:927384; doi: 10.3389/fphar.2022.927384
30.
XingY, CuiY, XuG, et al.Protective effect of Platycodon grandiflorus polysaccharide on apoptosis and mitochondrial damage induced by pseudorabies virus in PK-15 cells. Cell Biochem Biophys, 2023; 81(3):493–502; doi: 10.1007/s12013-023-01141-4
31.
EmadiA, JonesRJ, BrodskyRA. Cyclophosphamide and cancer: Golden anniversary. Nat Rev Clin Oncol, 2009; 6(11):638–647; doi: 10.1038/nrclinonc.2009.146
32.
KimWI, LimJO, PakSW, et al.Diesel particulate matter aggravates cyclophosphamide-induced testicular toxicity in mice via elevating oxidative damage. Mol Cell Toxicol, 2024; 20(1):17–26; doi: 10.1007/s13273-022-00310-5
33.
OginoMHTp. Cyclophosphamide. Treasure Island (FL): StatPearls Publishing. 2024.
34.
QianP, PengCH, YeX. Interstitial pneumonia induced by cyclophosphamide: A case report and review of the literature. Respir Med Case Rep, 2019; 26:212–214; doi: 10.1016/j.rmcr.2019.01.014
35.
WangF, LiN, LiH, et al.An alkali-extracted neutral heteropolysaccharide from Phellinus nigricans used as an immunopotentiator in immunosuppressed mice by activating macrophages. Carbohydr Polym, 2024; 335:122110; doi: 10.1016/j.carbpol.2024.122110
36.
MorgansLF, BurnsER. Effect of cyclophosphamide on circadian rhythms in mitosis and DNA synthesis in normal mice and mice bearing the Ehrlich ascites carcinoma. Oncology, 1984; 41(2):135–139; doi: 10.1159/000225808
37.
LiuYJ, ShiL, QiuWH, et al.Ferulic acid exhibits anti-inflammatory effects by inducing autophagy and blocking NLRP3 inflammasome activation. Mol Cell Toxicol, 2022; 18(4):509–519; doi: 10.1007/s13273-021-00219-5
38.
AnN, YangT, ZhangX-X, et al.Bergamottin alleviates LPS-induced acute lung injury by inducing SIRT1 and suppressing NF-κB. Innate Immun, 2021; 27(7–8):543–552; doi: 10.1177/17534259211062553
39.
JiaQ, WenJ, YangQ, et al.Lonicera japonica Thunb extract ameliorates lipopolysaccharide-induced acute lung injury associated with luteolin-mediated suppression of NF-κB signaling pathway. J Inflamm (Lond), 2023; 20(1):44; doi: 10.1186/s12950-023-00372-9
40.
LeeCY, ChenSP, Huang-LiuR, et al.Fucoxanthin decreases lipopolysaccharide-induced acute lung injury through the inhibition of RhoA activation and the NF-κB pathway. Environ Toxicol, 2022; 37(9):2214–2222; doi: 10.1002/tox.23587
41.
PengL-Y, ShiH-T, YuanM, et al.Madecassoside protects against LPS-Induced acute lung injury via inhibiting TLR4/NF-κB activation and blood-air barrier permeability. Front Pharmacol, 2020; 11:807; doi: 10.3389/fphar.2020.00807
42.
ShenB, ZhangH, ZhuZ, et al.Baicalin Relieves LPS-Induced lung inflammation via the NF-κB and MAPK pathways. Molecules, 2023; 28(4):1873; doi: 10.3390/molecules28041873
43.
LamichhaneG, PandeyaPR, LamichhaneR, et al.Evaluation of anti-inflammatory potential of extract, fractions and major compounds of Ponciri Fructus in LPS-induced RAW 264.7 cells. Curr Res Biotechnol, 2023; 6:100138; doi: 10.1016/j.crbiot.2023.100138
44.
KhajuriaV, GuptaS, SharmaN, et al.Anti-inflammatory potential of hentriacontane in LPS stimulated RAW 264.7 cells and mice model. Biomed Pharmacother, 2017; 92:175–186; doi: 10.1016/j.biopha.2017.05.063
45.
GaoW, GuoY, YangH. Platycodin D protects against cigarette smoke-induced lung inflammation in mice. Int Immunopharmacol, 2017; 47:53–58; doi: 10.1016/j.intimp.2017.03.009
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
